McKesson Corporation (LON:0JZU)
London · Delayed Price · Currency is GBP · Price in USD 830.36
+4.92 (0.60%)
At close: Jan 30, 2026
McKesson Market Cap
McKesson has a market cap or net worth of 74.78 billion as of January 30, 2026. Its market cap has increased by 23.56% in one year.
Market Cap
74.78B
Enterprise Value
79.97B
Revenue
287.97B
Ranking
n/a
PE Ratio
24.92
Stock Price
830.36
Market Cap Chart
Since November 10, 1994, McKesson's market cap has increased from 904.45M to 74.78B, an increase of 8,168.20%. That is a compound annual growth rate of 15.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 74.78B | -0.59% |
| Dec 31, 2025 | 75.23B | 30.18% |
| Dec 31, 2024 | 57.79B | 19.48% |
| Dec 29, 2023 | 48.37B | 9.56% |
| Dec 30, 2022 | 44.14B | 57.50% |
| Dec 31, 2021 | 28.03B | 37.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.92B |
| GSK plc | 75.29B |
| Haleon | 33.75B |
| Smith & Nephew | 10.55B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.11B |
| HUTCHMED (China) | 1.89B |